Cargando…
The use of alpha 1 thymosin as an immunomodulator of the response against SARS-Cov2
BACKGROUND: Since the beginning of SARS-CoV2 pandemic, the mortality rate among elderly patients (60–90 years) has been around 50%, so age has been a determining factor of a worse COVID-19 prognosis. Associated with age, the thymic function involution and depletion plays an important role, that coul...
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10320944/ https://www.ncbi.nlm.nih.gov/pubmed/37408063 http://dx.doi.org/10.1186/s12979-023-00351-x |